272 related articles for article (PubMed ID: 26864297)
1. Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome.
Lee JS; Ahn JY; Choi KD; Song HJ; Kim YH; Lee GH; Jung HY; Ryu JS; Kim SB; Kim JH; Park SI; Cho KJ; Kim JH
Korean J Intern Med; 2016 Mar; 31(2):253-9. PubMed ID: 26864297
[TBL] [Abstract][Full Text] [Related]
2. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.
Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y
Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
[TBL] [Abstract][Full Text] [Related]
4. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Su YY; Shih LH; Li SH
Sci Rep; 2017 Jan; 7():41785. PubMed ID: 28134308
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer.
Miyazaki T; Sohda M; Higuchi T; Tanaka N; Suzuki S; Sakai M; Yokobori T; Nakajima M; Fukuchi M; Tsushima Y; Kato H; Kuwano H
Anticancer Res; 2014 Jan; 34(1):283-7. PubMed ID: 24403475
[TBL] [Abstract][Full Text] [Related]
6. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
[TBL] [Abstract][Full Text] [Related]
7. Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.
Hanamoto A; Takenaka Y; Shimosegawa E; Ymamamoto Y; Yoshii T; Nakahara S; Hatazawa J; Inohara H
Ann Nucl Med; 2013 Dec; 27(10):880-5. PubMed ID: 23979967
[TBL] [Abstract][Full Text] [Related]
8. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
[TBL] [Abstract][Full Text] [Related]
9. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.
Katada C; Yokoyama T; Yano T; Kaneko K; Oda I; Shimizu Y; Doyama H; Koike T; Takizawa K; Hirao M; Okada H; Yoshii T; Konishi K; Yamanouchi T; Tsuda T; Omori T; Kobayashi N; Shimoda T; Ochiai A; Amanuma Y; Ohashi S; Matsuda T; Ishikawa H; Yokoyama A; Muto M
Gastroenterology; 2016 Nov; 151(5):860-869.e7. PubMed ID: 27492616
[TBL] [Abstract][Full Text] [Related]
10. Rigid Esophagoscopy for Head and Neck Cancer Staging and the Incidence of Synchronous Esophageal Malignant Neoplasms.
McGarey PO; O'Rourke AK; Owen SR; Shonka DC; Reibel JF; Levine PA; Jameson MJ
JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):40-5. PubMed ID: 26633039
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
12. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
[TBL] [Abstract][Full Text] [Related]
13. Esophageal cancers with synchronous or antecedent head and neck cancers: a more formidable challenge?
Lo OS; Law S; Wei WI; Ng WM; Wong KH; Tong KH; Wong J
Ann Surg Oncol; 2008 Jun; 15(6):1750-6. PubMed ID: 18347873
[TBL] [Abstract][Full Text] [Related]
14. A case of simultaneous esophageal squamous cell carcinoma and Barrett's adenocarcinoma.
Yamazaki T; Iwaya Y; Iwaya M; Watanabe T; Seki A; Ochi Y; Hara E; Sekiguchi T; Hosaka N; Arakura N; Tanaka E; Hasebe O
Clin J Gastroenterol; 2016 Aug; 9(4):222-7. PubMed ID: 27220657
[TBL] [Abstract][Full Text] [Related]
15. PET/CT in the evaluation of treatment response to neoadjuvant chemoradiotherapy and prognostication in patients with locally advanced esophageal squamous cell carcinoma.
Yuan H; Tong DK; Vardhanabhuti V; Law SY; Chiu KW; Khong PL
Nucl Med Commun; 2016 Sep; 37(9):947-55. PubMed ID: 27145438
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of the Maximum Standardized Uptake Value on Positron Emission Tomography for Esophageal Squamous Cell Carcinoma.
Jeon HW; Kim KS; Sung SW; Park HJ; Kim YD; Park JK
Thorac Cardiovasc Surg; 2015 Jun; 63(4):341-8. PubMed ID: 25322264
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Resection of Synchronous Esophageal and Gastric Cancers.
Park B; Kim HK; Choi YS; Kim J; Zo JI; Shim YM
Thorac Cardiovasc Surg; 2016 Oct; 64(7):611-618. PubMed ID: 27148930
[No Abstract] [Full Text] [Related]
18. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
[TBL] [Abstract][Full Text] [Related]
19. Impact of PET-CT on primary staging and response control on multimodal treatment of esophageal cancer.
Thurau K; Palmes D; Franzius C; Minin E; Senninger N; Juergens KU; Bruewer M
World J Surg; 2011 Mar; 35(3):608-16. PubMed ID: 21221582
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of endoscopic ultrasonography non-traversability in patients with locoregional esophageal cancer receiving multimodality therapy.
Cho CJ; Song HJ; Lee GH; Choi KD; Kim YH; Ryu JS; Kim SB; Kim JH; Park SI; Jung HY
Korean J Intern Med; 2017 May; 32(3):443-451. PubMed ID: 26972059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
